PT839913E - METHOD OF EXPRESSION OF POLYEPEPTIDES IN FISH BY IMMERSE IN A PLASMIDIC DNA SOLUTION - Google Patents

METHOD OF EXPRESSION OF POLYEPEPTIDES IN FISH BY IMMERSE IN A PLASMIDIC DNA SOLUTION

Info

Publication number
PT839913E
PT839913E PT97119273T PT97119273T PT839913E PT 839913 E PT839913 E PT 839913E PT 97119273 T PT97119273 T PT 97119273T PT 97119273 T PT97119273 T PT 97119273T PT 839913 E PT839913 E PT 839913E
Authority
PT
Portugal
Prior art keywords
methods
aquaculture
fish
expression systems
polyepeptides
Prior art date
Application number
PT97119273T
Other languages
Portuguese (pt)
Inventor
Heather L Davis
Original Assignee
Ottawa Health Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/740,805 external-priority patent/US5780448A/en
Application filed by Ottawa Health Research Inst filed Critical Ottawa Health Research Inst
Publication of PT839913E publication Critical patent/PT839913E/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Farming Of Fish And Shellfish (AREA)

Abstract

The present invention relates to methods of immunization of aquaculture species by introducing DNA expression systems into the aquaculture species. Such DNA expression systems preferably include DNA sequences encoding polypeptides of pathogens of species of aquaculture. The present invention also relates to methods of administration of DNA expression systems into aquaculture. Such methods include injection, spray, and immersion techniques. The methods of this invention are useful for prophylactic vaccination or therapeutic immunization of fin-fish, shellfish, or other aquatic animals against infectious diseases.
PT97119273T 1996-11-04 1997-11-04 METHOD OF EXPRESSION OF POLYEPEPTIDES IN FISH BY IMMERSE IN A PLASMIDIC DNA SOLUTION PT839913E (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/740,805 US5780448A (en) 1995-11-07 1996-11-04 DNA-based vaccination of fish
EP96117859A EP0773295B1 (en) 1995-11-07 1996-11-07 Method for expressing polypeptides in fish by immersion in DNA-plasmid solution

Publications (1)

Publication Number Publication Date
PT839913E true PT839913E (en) 2006-09-29

Family

ID=36686672

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97119273T PT839913E (en) 1996-11-04 1997-11-04 METHOD OF EXPRESSION OF POLYEPEPTIDES IN FISH BY IMMERSE IN A PLASMIDIC DNA SOLUTION

Country Status (5)

Country Link
EP (1) EP0839913B1 (en)
AT (1) ATE331030T1 (en)
DE (1) DE69736163T2 (en)
ES (1) ES2268719T3 (en)
PT (1) PT839913E (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO311648B1 (en) 1999-05-31 2001-12-27 Genomar Asa DNA sequences that can be used for vaccine, preventive health work on fish and aquatic organisms and otherwise within biomedicine, vector, ILA virus vaccine and diagnostic set
DK1094069T4 (en) * 1999-10-18 2008-07-21 Intervet Int Bv DNA encoding structural protein-1 from infectious salmon anemia virus and its applications
WO2001049712A2 (en) * 2000-01-07 2001-07-12 Akzo Nobel N.V. Vaccine against isav (infectious salmon anaemia virus)
DE10317079A1 (en) * 2003-04-12 2005-02-03 Scheller, Albert, Dr. Storage material for a biological, medical or homeopathic active ingredient is made from a hollow fiber or has a hollow fiber-like section

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5076208A (en) * 1990-09-14 1991-12-31 Massachusetts Institute Of Technology Ultrasound-mediated administration of compounds into aquatic animals
US5512421A (en) * 1991-02-19 1996-04-30 The Regents Of The University Of California Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
IT1256575B (en) * 1992-12-10 1995-12-11 Cesalpino Andrea Fond PROCEDURE FOR THE PREPARATION OF IMMUNOGENS CONSTITUTED BY EXOGENOUS ANTIGENS CAPABLE OF GENERATING NOT ONLY THE IMMUNE RESPONSE OF T HELPER LYMPHOCYTES, BUT ALSO AN EFFECTIVE RESPONSE OF CYTOTOXIC T LYMPHOCYTES; AND IMMUNOGENES SO OBTAINABLE.
FR2719316B1 (en) * 1994-04-28 1996-05-31 Idm New nucleic acid and polymer complexes, their preparation process and their use for cell transfection.
WO1996003034A1 (en) * 1994-07-27 1996-02-08 Massachusetts Institute Of Technology Method for retroviral vector insertion in fish
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish

Also Published As

Publication number Publication date
EP0839913A3 (en) 1999-06-16
DE69736163D1 (en) 2006-08-03
ATE331030T1 (en) 2006-07-15
EP0839913B1 (en) 2006-06-21
ES2268719T3 (en) 2007-03-16
DE69736163T2 (en) 2007-05-03
EP0839913A2 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
EP0773295A3 (en) DNA-based vaccination of fish by immersion
DE69939747D1 (en) METHOD OF DNA VACCINATION
FI113969B (en) Method for Preparation of Soluble Ligand for CD40, Ligand Coding Nucleic Acid Sequence, and Use of the Ligand
CY1111267T1 (en) DIAGNOSTIC BIRDS AND PRODUCTION OF PROTEINS
EA200100565A1 (en) NEW STRIPT COCK ANTIGENS
DE60310562D1 (en) METHOD FOR REINFORCING AN IMMUNE RESPONSE OF NUCLEIC ACID VACCINATION
ATE126537T1 (en) DIAGNOSTICS FOR THE INFECTIOUS FELINE PERITENTASIS VIRUS.
DE69535374D1 (en) ACTIVE IMMUNIZATION AGAINST A SIDEROPHORES RECEPTOR PROTEIN
HUT71847A (en) Dna molecules encoding aminopeptidase enzymes, vectors and transgenic cells containing dna molecules, immunogenic polypeptides encoding by dna molecules, vaccines against helminth infections containing these peptides and process for the preparation ...
DK482788A (en) VACCINES AGAINST AND DIAGNOSTIC PROVISIONS OF HAEMOPHILUS INFLUENZAE
PT839913E (en) METHOD OF EXPRESSION OF POLYEPEPTIDES IN FISH BY IMMERSE IN A PLASMIDIC DNA SOLUTION
RU97106340A (en) DNA ENCODING PAPILOMAVIRUS OF HUMAN TYPE 6A
DE69530570D1 (en) METHOD FOR TREATING HUMAN OR ANIMAL BODY DISTURBATION BY ADMINISTRATING AMINO ACIDS
DE3785033D1 (en) METHOD FOR OBTAINING IMMUNEGULATING FACTORS BY MEANS OF MAMMAL IMMUNIZATION.
ATE517629T1 (en) USE OF A PROTEIN OF THE CRMP FAMILY TO TREAT IMMUNE SYSTEM DISEASES
DE69202522D1 (en) Process for depilation of animal skins.
PT1141305E (en) CHIMERIC GENE FORMED BY DNA SEQUENCES THAT CODIFIES THE ANTIGENIC DETERMINANTS OF FOUR PROTEINS BY L. INFANTUM
DK0709460T3 (en) Poultry vaccine against coccidiosis
MX9805158A (en) Dna encoding a plasminogen activating protein.
DE3775461D1 (en) METHOD FOR TREATING REINFORCED POLYMER COMPOSITES.
ATE219513T1 (en) MOLECULAR CLONING OF GENOMIC AND CDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS
IL88622A0 (en) Dna sequences which code for an antigenic protein,antigens coded for by said dna sequences and a vaccine and method for protecting birds using the same
ATE522212T1 (en) NEOMYCIN FOR INCREASE THE SURVIVAL OF AQUATIC ANIMALS EXPOSED TO IPNV
FR2724385B1 (en) FELINE INFECTIOUS PERITONITIS VACCINE.
DE69521281D1 (en) Process for the production of human or human matrilysin by means of recombinant DNA.